On Dec. 23, 2022, federal agencies released an FAQ stating that they will not initiate enforcement action against any plan or issuer that makes a good faith effort to submit their prescription drug data by Jan. 31, 2023. This Legal Update explains further.
Continue![Submission Grace Period Issued for Prescription Drug Reporting](https://capital-services.com/wp-content/uploads/2022/06/Screen-Shot-2022-06-13-at-5.26.12-PM-900x600.png)